{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:41:07Z","timestamp":1791848467982,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.virusres.2013.09.016","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T02:16:58Z","timestamp":1379384218000},"page":"374-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain"],"prefix":"10.1016","volume":"178","author":[{"given":"Massimiliano","family":"Bissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sole Maria","family":"Pacchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Zanotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"De Giuli Morghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Illiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Granucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2013.09.016_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/rmv.571","article-title":"New generation smallpox vaccines: a review of preclinical and clinical data","volume":"18","author":"Artenstein","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0010","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1128\/JVI.00068-08","article-title":"Multifunctional T-cell characteristics induced by a polyvalent DNA prime\/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration","volume":"82","author":"Bansal","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0264-410X(92)90411-C","article-title":"Potential use of nonreplicating vectors as recombinant vaccines","volume":"10","author":"Baxby","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0020","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(03)00008-1","article-title":"Pathogenesis and potential antiviral therapy of complications of smallpox vaccination","volume":"58","author":"Bray","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2013.09.016_bib0030","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0035","first-page":"1513","article-title":"Cowpox virus in llama, Italy","volume":"17","author":"Cardeti","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virusres.2013.09.016_bib0040","first-page":"478","article-title":"Household transmission of vaccinia virus from contact with a military smallpox vaccinee\u2014Illinois and Indiana, 2007","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.virusres.2013.09.016_bib0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2007.02.041","article-title":"Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate","volume":"366","author":"Earl","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2013.09.016_bib0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2013.09.016_bib0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1086\/427265","article-title":"Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge","volume":"191","author":"Edghill-Smith","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2013.09.016_bib0060","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2013.09.016_bib0065","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.vaccine.2007.12.059","article-title":"Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine","volume":"26","author":"Ferrier-Rembert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0070","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"Fogg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0075","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0080","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/erv.11.46","article-title":"The strategic use of novel smallpox vaccines in the post-eradication world","volume":"10","author":"Golden","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virusres.2013.09.016_bib0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1743-422X-8-441","article-title":"Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease","volume":"8","author":"Golden","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2013.09.016_bib0090","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.1200799","article-title":"CD8T cells are essential for recovery from a respiratory vaccinia virus infection","volume":"189","author":"Goulding","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0095","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.09.55","article-title":"The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks","volume":"8","author":"Handley","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virusres.2013.09.016_bib0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/infdis\/jiq017","article-title":"Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge","volume":"203","author":"Hirao","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2013.09.016_bib0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicitis appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2013.09.016_bib0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.vaccine.2009.09.133","article-title":"Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates","volume":"28","author":"Hooper","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/eid0703.017311","article-title":"Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997","volume":"7","author":"Hutin","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virusres.2013.09.016_bib0120","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.vaccine.2008.05.044","article-title":"US military service members vaccinated against smallpox in 2003 and 2004 experience a slightly higher risk of hospitalization postvaccination","volume":"26","author":"Jacobson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virusres.2013.09.016_bib0130","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1045-1870(03)00032-3","article-title":"Adverse events occurring after smallpox vaccination","volume":"14","author":"Lane","year":"2003","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.virusres.2013.09.016_bib0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001432-200404000-00003","article-title":"Zoonotic poxvirus infections in humans","volume":"17","author":"Lewis-Jones","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.virusres.2013.09.016_bib0145","doi-asserted-by":"crossref","first-page":"970424","DOI":"10.1155\/2011\/970424","article-title":"Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain","volume":"2011","author":"Lu","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid1801.110692","article-title":"Vaccinia virus zoonotic infection, S\u00e3o Paulo State, Brazil","volume":"18","author":"Megid","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virusres.2013.09.016_bib0160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.vaccine.2010.10.064","article-title":"VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone","volume":"29","author":"Moise","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virusres.2013.09.016_bib0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.virusres.2013.09.016_bib0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1743-422X-6-55","article-title":"In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate","volume":"6","author":"Okeke","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2013.09.016_bib0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1479-5876-11-95","article-title":"L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines","volume":"11","author":"Pacchioni","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.virusres.2013.09.016_bib0185","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function","volume":"80","author":"Panchanathan","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0190","first-page":"362","article-title":"Smallpox vaccines: from first to second to third generation","volume":"365","author":"Poland","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jviromet.2009.01.021","article-title":"Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins","volume":"158","author":"Pozzi","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2013.09.016_bib0200","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.vaccine.2006.11.009","article-title":"Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells","volume":"25","author":"Radaelli","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0205","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0264-410X(94)90181-3","article-title":"Humoral and cell mediated immunity in rabbits immunized with live non replicating avipox recombinants expressing the HIV-1sf2 env gene","volume":"12","author":"Radaelli","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(03)00184-3","article-title":"Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251","volume":"312","author":"Radaelli","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2013.09.016_bib0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1479-5876-8-40","article-title":"Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits","volume":"8","author":"Radaelli","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.virusres.2013.09.016_bib0220","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.virusres.2013.09.016_bib0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tim.2008.07.009","article-title":"Vaccinia virus morphogenesis and dissemination","volume":"16","author":"Roberts","year":"2008","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/JVI.60.2.436-449.1986","article-title":"Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the Hindlll H genome fragment","volume":"60","author":"Rosel","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0235","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox","volume":"52","author":"Sarkar","year":"1975","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.virusres.2013.09.016_bib0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1863-2378.2007.00995.x","article-title":"Generalized fatal Cowpox virus infection in a cat with transmission to a human contact case","volume":"54","author":"Schulze","year":"2007","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.virusres.2013.09.016_bib0245","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0250","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2011.03.013","article-title":"Joint production of prime\/boost pairs of Fowlpox virus and modified vaccinia Ankara recombinants carrying the same transgene","volume":"174","author":"Soprana","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2013.09.016_bib0260","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.vaccine.2010.02.006","article-title":"Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity","volume":"28","author":"Vaine","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0265","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination","volume":"30","author":"Verheust","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0270","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2340\/00015555-1227","article-title":"The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats","volume":"92","author":"Vogel","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.virusres.2013.09.016_bib0275","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.vaccine.2008.04.073","article-title":"Heterologous HA DNA vaccine prime\u2013inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0280","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2013.09.016_bib0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0166-3542(02)00195-X","article-title":"Smallpox: a potential agent of bioterrorism","volume":"57","author":"Whitley","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2013.09.016_bib0290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0042-6822(86)90405-8","article-title":"Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus","volume":"148","author":"Wilton","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2013.09.016_bib0295","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.09.016_bib0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2010.07.005","article-title":"Canarypox and fowlpox viruses as recombinant vaccine vectors: a biological and immunological comparison","volume":"88","author":"Zanotto","year":"2010","journal-title":"Antiviral Res."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170213003080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170213003080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T04:03:37Z","timestamp":1596513817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170213003080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0168170213003080"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2013.09.016","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2013.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}